Pfizer has launched messenger RNA (mRNA) collaborations with four companies, including an up-to-$1.35 billion partnership with base editing developer Beam Therapeutics, alliances with Codex DNA and Acuitas Therapeutics, and a third mRNA vaccine partnership with BioNTech.